Literature DB >> 21928297

Pharmacological effects and pharmacokinetics properties of Radix Scutellariae and its bioactive flavones.

Chenrui Li1, Ge Lin, Zhong Zuo.   

Abstract

Radix Scutellariae is the dried root of the medicinal plant Scutellariae baicalensis Georgi. It exhibits a variety of therapeutic effects and has a long history of application in traditional formulations as well as in modern herbal medications. It has been confirmed that flavonoids are the most abundant constituents and induce these therapeutic effects. Six flavones are proven to be the major bioactive flavones in Radix Scutellariae existing in the forms of aglycones (baicalein, wogonin, oroxylin A) and glycosides (baicalin, wogonoside, oroxylin A-7-glucuronide). All six flavones are pharmacologically active and show great potential in the treatment of inflammation, cancers and virus-related diseases. The current review covers the preparation of the herb Radix Scutellariae, quantification of its major bioactive ingredients, and pharmacological effects of the proposed six bioactive flavones. In addition, this review summarizes the pharmacokinetic profiles of the bioactive flavones reported so far that could be used for further improvement of their pharmacokinetic study. Moreover, due to abundant co-occurring bioactive components in Radix Scutellariae, our review further documents the pharmacokinetic interactions among them.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21928297     DOI: 10.1002/bdd.771

Source DB:  PubMed          Journal:  Biopharm Drug Dispos        ISSN: 0142-2782            Impact factor:   1.627


  59 in total

Review 1.  Therapeutic Potential of Baicalein in Alzheimer's Disease and Parkinson's Disease.

Authors:  Yanwei Li; Jinying Zhao; Christian Hölscher
Journal:  CNS Drugs       Date:  2017-08       Impact factor: 5.749

2.  Effects of baicalin cream in two mouse models: 2,4-dinitrofluorobenzene-induced contact hypersensitivity and mouse tail test for psoriasis.

Authors:  Jie Wu; Hong Li; Ming Li
Journal:  Int J Clin Exp Med       Date:  2015-02-15

3.  Anticancer properties of baicalein: a review.

Authors:  Ying Gao; Shane A Snyder; Jaclyn N Smith; Yi Charlie Chen
Journal:  Med Chem Res       Date:  2016-06-29       Impact factor: 1.965

4.  Wogonoside induces apoptosis in Bel-7402, a hepatocellular carcinoma cell line, by regulating Bax/Bcl-2.

Authors:  Yusheng Li; Min Tu; Chao Cheng; Jian Tian; Fangjie Zhang; Zhenhan Deng; Xuan'an Li; Zhongkui Li; Yanping Liu; Guanghua Lei
Journal:  Oncol Lett       Date:  2015-06-22       Impact factor: 2.967

5.  Pharmacokinetic Characteristics of Baicalin in Rats with 17α-ethynyl-estradiol-induced Intrahepatic Cholestasis.

Authors:  Cheng-Liang Zhang; Yan-Jiao Xu; Dong Xiang; Jin-Yu Yang; Kai Lei; Dong Liu
Journal:  Curr Med Sci       Date:  2018-03-15

6.  Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway.

Authors:  Qian Chen; Mengyang Liu; Haiyang Yu; Jian Li; Sijian Wang; Yi Zhang; Feng Qiu; Tao Wang
Journal:  J Nat Med       Date:  2018-03-14       Impact factor: 2.343

7.  Baicalein protects mice against radiation-induced DNA damages and genotoxicity.

Authors:  Nitin Motilal Gandhi
Journal:  Mol Cell Biochem       Date:  2013-04-20       Impact factor: 3.396

Review 8.  Herbals and Plants in the Treatment of Pancreatic Cancer: A Systematic Review of Experimental and Clinical Studies.

Authors:  John K Triantafillidis; Eleni Triantafyllidi; Michail Sideris; Theodoros Pittaras; Apostolos E Papalois
Journal:  Nutrients       Date:  2022-01-30       Impact factor: 5.717

9.  Baicalein inhibits the pharmacokinetics of simvastatin in rats via regulating the activity of CYP3A4.

Authors:  Meng Meng; Xin Li; Xiuwen Zhang; Bin Sun
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

10.  CaMKKβ is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell lines.

Authors:  Ying Ma; Fuzhen Yang; Ying Wang; Zhiyan Du; Daihua Liu; Hongxia Guo; Jingkang Shen; Hongli Peng
Journal:  PLoS One       Date:  2012-10-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.